Patents by Inventor Marco Rabinovitz

Marco Rabinovitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of inhibiting transformed cells
    Patent number: 5545639
    Abstract: The present invention relates to a method for the inhibition of transformed cells, comprising the application of an effective amount of at least one of the group consisting of 2,9-bis(halomethyl)-1,10-phenanthroline and structural congeners thereof.
    Type: Grant
    Filed: February 18, 1994
    Date of Patent: August 13, 1996
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Marco Rabinovitz, Joyce M. Fisher
  • Method for the treatment of cancer by use of the copper complex of S-(methylthio)-DL-homocysteine or the L-enantiomorph thereof
    Patent number: 5385933
    Abstract: A composition and a method for inhibiting cellular proliferation, such as the abnormal cellular proliferation characteristic of cancer cells. The method comprises the administration to a mammal, in particular a human, of an effective amount of S-(methylthio)-DL-homocysteine or S-(methylthio)-L-homocysteine, either simultaneously or sequentially, with an effective amount of a copper chelate such that an effective amount of an inhibitory complex forms in the mammal between the S-(methylthio)-homocysteine and the copper of the cooper chelate. The inhibitory complex is capable of inhibiting the proliferation of cells contacted by the inhibitory complex.
    Type: Grant
    Filed: June 19, 1992
    Date of Patent: January 31, 1995
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Marco Rabinovitz, Joyce M. Fisher
  • Pharmaceutical compositions for the treatment of cancers susceptible to treatment with the copper complex of S-(methylthio)-DL-homocysteine or the L-enantimorph thereof
    Patent number: 5124351
    Abstract: An injectable pharmaceutical composition for the treatment of cancers susceptible to treatment therewith, the composition comprising:(a) an effective amount of S-(methylthio)-DL-homocysteine or the L-enantimorph thereof;(b) an effective amount of a copper chelate of nitrilotriacetic acid or an effective amount of a copper chelate of a bis-thiosemicarbazone; and(c) a pharmaceutically acceptable carrier.
    Type: Grant
    Filed: February 27, 1989
    Date of Patent: June 23, 1992
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Marco Rabinovitz, Joyce M. Fisher
  • Chemotherapeutic 1-(2-chloroethyl)-4-(3-chloropropyl)-piperazine, dihydrochloride
    Patent number: 4755515
    Abstract: New nitrogen mustard analogs with arms of unequal reactivity on different nitrogen atoms have been made. The new analogs are less toxic, potent, cancer chemotherapentic agents.
    Type: Grant
    Filed: August 14, 1986
    Date of Patent: July 5, 1988
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Marco Rabinovitz